Volume 125; Issue 20

Main
Blood
Volume 125; Issue 20

Blood

Volume 125; Issue 20

1

Phase 1/2 study of carfilzomib plus melphalan and prednisone in patients aged over 65 years with newly diagnosed multiple myeloma

Moreau, P., Kolb, B., Attal, M., Caillot, D., Benboubker, L., Tiab, M., Touzeau, C., Leleu, X., Roussel, M., Chaleteix, C., Planche, L., Chiffoleau, A., Fortin, J., Avet-Loiseau, H., Mary, J.-Y., Huli

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 225 KB

english, 2015

2

Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia

Hing, Z. A., Mantel, R., Beckwith, K. A., Guinn, D., Williams, E., Smith, L. L., Williams, K., Johnson, A. J., Lehman, A. M., Byrd, J. C., Woyach, J. A., Lapalombella, R.

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 110 KB

english, 2015

3

Frontline therapy of multiple myeloma

Moreau, P., Attal, M., Facon, T.

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 380 KB

english, 2015

4

Introduction to a series of reviews on multiple myeloma

San Miguel, J. F.

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 43 KB

english, 2015

5

Smoldering multiple myeloma

Rajkumar, S. V., Landgren, O., Mateos, M.-V.

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 153 KB

english, 2015

6

New criteria for response assessment: role of minimal residual disease in multiple myeloma

Paiva, B., van Dongen, J. J. M., Orfao, A.

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 327 KB

english, 2015

7

The IL-33/ST2 axis augments effector T-cell responses during acute GVHD

Reichenbach, D. K., Schwarze, V., Matta, B. M., Tkachev, V., Lieberknecht, E., Liu, Q., Koehn, B. H., Pfeifer, D., Taylor, P. A., Prinz, G., Dierbach, H., Stickel, N., Beck, Y., Warncke, M., Junt, T.,

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 1.31 MB

english, 2015

8

Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans

Nakasone, H., Tian, L., Sahaf, B., Kawase, T., Schoenrock, K., Perloff, S., Ryan, C. E., Paul, J., Popli, R., Wu, F., Otani, J. M., Coller, J., Warren, E. H., Miklos, D. B.

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 1.28 MB

english, 2015

9

Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approach

Nonami, A., Sattler, M., Weisberg, E., Liu, Q., Zhang, J., Patricelli, M. P., Christie, A. L., Saur, A. M., Kohl, N. E., Kung, A. L., Yoon, H., Sim, T., Gray, N. S., Griffin, J. D.

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 1.84 MB

english, 2015

10

Perivascular deletion of murine Rac reverses the ratio of marrow arterioles and sinusoid vessels and alters hematopoiesis in vivo

Ciuculescu, M. F., Park, S.-Y., Canty, K., Mathieu, R., Silberstein, L. E., Williams, D. A.

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 1.55 MB

english, 2015

11

IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells

Schinke, C., Giricz, O., Li, W., Shastri, A., Gordon, S., Barreyro, L., Bhagat, T., Bhattacharyya, S., Ramachandra, N., Bartenstein, M., Pellagatti, A., Boultwood, J., Wickrema, A., Yu, Y., Will, B.,

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 2.59 MB

english, 2015

12

The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF- B positive feedback loop in peripheral T-cell lymphoma

Boddicker, R. L., Kip, N. S., Xing, X., Zeng, Y., Yang, Z.-Z., Lee, J.-H., Almada, L. L., Elsawa, S. F., Knudson, R. A., Law, M. E., Ketterling, R. P., Cunningham, J. M., Wu, Y., Maurer, M. J., O'Byrn

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 1.43 MB

english, 2015